Disease activity and damage in juvenile idiopathic arthritis: methotrexate era versus biologic era

被引：0
|
作者：
Gabriella Giancane
Valentina Muratore
Valentina Marzetti
Neus Quilis
Belen Serrano Benavente
Francesca Bagnasco
Alessandra Alongi
Adele Civino
Lorenzo Quartulli
Alessandro Consolaro
Angelo Ravelli
机构：
[1] Università degli Studi di Genova,Dipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno
[2] IRCCS G. Gaslini,Infantili
[3] IRCCS Fondazione Policlinico San Matteo,Clinica Pediatrica e Reumatologia
[4] Ospedale Vito Fazzi,Clinica Pediatrica
[5] Azienda Ospedaliera Cardinale G. Panico,UOC Pediatria
[6] Sechenov First Moscow State Medical University,undefined
来源：
Arthritis Research & Therapy | / 21卷
关键词：
Juvenile idiopathic arthritis; Disease activity; Disease damage; Long-term outcome; Methotrexate; Biologic agents;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Disease activity and damage in juvenile idiopathic arthritis: methotrexate era versus biologic era
    Giancane, Gabriella
    Muratore, Valentina
    Marzetti, Valentina
    Quilis, Neus
    Benavente, Belen Serrano
    Bagnasco, Francesca
    Alongi, Alessandra
    Civino, Adele
    Quartulli, Lorenzo
    Consolaro, Alessandro
    Ravelli, Angelo
    ARTHRITIS RESEARCH & THERAPY, 2019, 21 (1)
  • [2] Juvenile idiopathic arthritis in the biologic era: predictors of the disease progression and need for early introduction of biologic treatment
    Panayiota Nalbanti
    Florentia Kanakoudi-Tsakalidou
    Maria Trachana
    Polyxeni Pratsidou-Gertsi
    Evangelia Farmaki
    Panagiotis Bamidis
    Fotios Papachristou
    Rheumatology International, 2018, 38 : 1241 - 1250
  • [3] Juvenile idiopathic arthritis in the biologic era: predictors of the disease progression and need for early introduction of biologic treatment
    Nalbanti, Panayiota
    Kanakoudi-Tsakalidou, Florentia
    Trachana, Maria
    Pratsidou-Gertsi, Polyxeni
    Farmaki, Evangelia
    Bamidis, Panagiotis
    Papachristou, Fotios
    RHEUMATOLOGY INTERNATIONAL, 2018, 38 (07) : 1241 - 1250
  • [4] The Humanistic and Economic Burden of Juvenile Idiopathic Arthritis in the era of Biologic Medication
    Wendy Gidman
    Rachel Meacock
    Deborah Symmons
    Current Rheumatology Reports, 2015, 17
  • [5] The Humanistic and Economic Burden of Juvenile Idiopathic Arthritis in the era of Biologic Medication
    Gidman, Wendy
    Meacock, Rachel
    Symmons, Deborah
    CURRENT RHEUMATOLOGY REPORTS, 2015, 17 (05)
  • [6] The role of synthetic drugs in the biologic era: therapeutic strategies for treating juvenile idiopathic arthritis
    Huegle, Boris
    Horneff, Gerd
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (05) : 703 - 714
  • [7] A modified juvenile arthritis damage index to improve articular damage assessment in juvenile idiopathic arthritis-enthesitis-related arthritis (JIA-ERA)
    Singh, Yogesh Preet
    Aggarwal, Amita
    CLINICAL RHEUMATOLOGY, 2012, 31 (05) : 767 - 774
  • [8] Treatment of Juvenile Idiopathic Arthritis in the Biologics Era
    Haas, J. -P.
    AKTUELLE RHEUMATOLOGIE, 2015, 40 (04) : 275 - 279
  • [9] Biologic Therapies in Juvenile Idiopathic Arthritis
    Tanatar, Ayse
    Ayaz, Nuray Aktay
    MEDICAL JOURNAL OF BAKIRKOY, 2023, 19 (03) : 269 - 275
  • [10] Functional status in severe juvenile idiopathic arthritis in the biologic treatment era: an assessment in a French paediatric rheumatology referral centre
    Boiu, Sorina
    Marniga, Elisa
    Bader-Meunier, Brigitte
    Mouy, Richard
    Compeyrot-Lacassagne, Sandrine
    Quartier, Pierre
    Wouters, Carine H.
    RHEUMATOLOGY, 2012, 51 (07) : 1285 - 1292
12345